R C Garner Selected Research

Hesperidin

1/2002

Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R C Garner Research Topics

Disease

2	Neoplasms (Cancer) 08/2007 - 04/2006
1	Body Weight (Weight, Body) 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 02/2003
1	Venous Insufficiency 01/2002
1	Breast Neoplasms (Breast Cancer) 12/2000

Drug/Important Bio-Agent (IBA)

2	AminesIBA 02/2003 - 12/2000
1	ixabepilone (BMS 247550)FDA Link 08/2007
1	5-aminolevulinic acid hexyl ester FDA Link 04/2006
1	AlbuminsIBA 04/2004
1	SmokeIBA 02/2003
1	AcetyltransferasesIBA 02/2003
1	FlavonoidsIBA 01/2002
1	HesperidinIBA 01/2002
1	Diosmin (Daflon)IBA 01/2002
1	benzocycloheptapyridineIBA 12/2000
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 12/2000

Therapy/Procedure

1	Catheters 04/2006